Literature DB >> 8371226

Postpartum cerebral infarction associated with aspirin withdrawal in the antiphospholipid antibody syndrome.

D Lê Thi Huong1, B Wechsler, P Edelman, A Fournié, Y Le Tallec, J C Piette, P Godeau.   

Abstract

We observed 2 cases of antiphospholipid syndrome complicated with hemiparesis appearing after delivery. During pregnancy, both women were systematically treated with aspirin (100 mg/day) in addition to prednisone in the second case. Cerebral infarction appeared a few hours after delivery and 8 days after discontinuation of aspirin. The close temporal relationship between discontinuation of aspirin and stroke occurring in early postpartum period suggests a causal link. If aspirin must be stopped for obstetrical reasons, we think that efficient anticoagulation should be started even if the presence of the antiphospholipid antibodies has been priorly asymptomatic.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8371226

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  9 in total

Review 1.  Update on the management of the pregnant patient with antiphospholipid antibody.

Authors:  L R Sammaritano
Journal:  Curr Rheumatol Rep       Date:  2001-06       Impact factor: 4.592

Review 2.  Treatment of the antiphospholipid syndrome.

Authors:  J C Piette; M Karmochkine; T Papo; L T Du; C Francès; B Wechsler
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

Review 3.  Evaluation of the obstetrical risks of the antiphospholipid syndrome and therapeutic management.

Authors:  P Edelman; A M Rouquette
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

4.  Long term anticoagulant treatment in the antiphospholipid syndrome.

Authors:  J C Piette; B Wechsler
Journal:  Ann Rheum Dis       Date:  1994-05       Impact factor: 19.103

Review 5.  Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview.

Authors:  Penka A Atanassova
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

Review 6.  The relation between antiphospholipid syndrome-related pregnancy morbidity and non-gravid vascular thrombosis: a review of the literature and management strategies.

Authors:  Doruk Erkan
Journal:  Curr Rheumatol Rep       Date:  2002-10       Impact factor: 4.592

Review 7.  Unusual manifestations of the antiphospholipid syndrome.

Authors:  Ronald A Asherson; Ricard Cervera
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

Review 8.  [Antiphospholipid antibody syndrome].

Authors:  R Schmidt; E H Scheuermann; A Viertel; H Geiger; I Scharrer
Journal:  Med Klin (Munich)       Date:  1999-02-15

9.  Recurrent fetal loss and antiphospholipid antibodies: clinical and therapeutic aspects.

Authors:  O Blétry; A M Piette
Journal:  Infect Dis Obstet Gynecol       Date:  1997
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.